The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–239 of 239
Rossi, J. M., Fegueux, N., Lu, Z., Legouffe, É., Exbrayat, C., Bozonnat, M., Navarro, R., Lopez, E., Quittet, P., Daurès, J., et al. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705138 · Cited by 60
Yoshio‐Hoshino, N., Adachi, Y., Aoki, C., Pereboev, A. V., Curiel, D. T., & Nishimoto, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3641 · Cited by 60
Regulation of ovarian carcinoma SKOV-3 cell proliferation and secretion of MMPs by autocrine IL-6.
Rabinovich, A., Medina, L., Piura, B., Segal, S., & Huleihel, M. (2007) · PubMed · Cited by 60
Tisi, M. C., Bozzoli, V., Giachelia, M., Massini, G., Ricerca, B. M., Maiolo, E., D’Alo’, F., Larocca, L. M., Piciocchi, A., Tjalsma, H., et al. (2014) · Leukemia & Lymphoma · doi:10.3109/10428194.2013.802314 · Cited by 59
Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma
Hoejberg, L., Bastholt, L., Johansen, J. S., Christensen, I. J., Gehl, J., & Schmidt, H. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e3283550aa5 · Cited by 59
Kudo, M., Jono, H., Shinriki, S., Yano, S., Nakamura, H., Makino, K., Hide, T., Muta, D., Ueda, M., Ota, K., et al. (2009) · Journal of neurosurgery · doi:10.3171/2008.12.jns081284 · Cited by 53
Interleukin 6 in Systemic Sclerosis and Potential Implications for Targeted Therapy
Muangchan, C., & Pope, J. E. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111423 · Cited by 51
Enomoto, A., Rho, M., Fukami, A., Hiraku, O., Komiyama, K., & Hayashi, M. (2004) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2004.08.196 · Cited by 50
Shimazaki, J., Goto, Y., Nishida, K., Tabuchi, T., Motohashi, G., Ubukata, H., & Tabuchi, T. (2013) · Oncology · doi:10.1159/000350836 · Cited by 48
Tassone, P., Galea, E., Forciniti, S., Tagliaferri, P., & Venuta, S. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.4.867 · Cited by 48
Tang, R.-F., Wang, S.-X., Zhang, F., Peng, L. J., Wang, S.-X., Xiao, Y., & Zhang, M. (2005) · PubMed · Cited by 46
Lemmers, A., Gustot, T., Durnez, A., Évrard, S., Moreno, C., Quertinmont, E., Vercruysse, V., Demetter, P., Franchimont, D. P., Moine, O. L., et al. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03916.x · Cited by 46
Immunotherapeutic Implication of IL-6 Blockade
Tanaka, T., & Kishimoto, T. (2011) · Immunotherapy · doi:10.2217/imt.11.147 · Cited by 46
Hillion, S., Garaud, S., Devauchelle‐Pensec, V., Bordron, A., Berthou, C., Youinou, P., & Jamin, C. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02649.x · Cited by 43
Suchi, K., Fujiwara, H., Okamura, S., Okamura, H., Umehara, S., Todo, M., Furutani, A., 米田, 政., Shiozaki, A., Kubota, T., et al. (2011) · PubMed · Cited by 42
Seavey, M. M., Lu, L. D., Stump, K. L., Wallace, N. H., Hockeimer, W., O’Kane, T. M., Ruggeri, B., & Dobrzański, P. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0951 · Cited by 42
Steiner, H., Cavarretta, I. T. R., Moser, P. L., Berger, A. P., Bektić, J., Dietrich, H., Zaki, M. H., Nakada, M. T., Hobisch, A., Nemeth, J. A., et al. (2006) · The Prostate · doi:10.1002/pros.20492 · Cited by 41
Mouawad, R., Rixe, O., Méric, J., Khayat, D., & Soubrane, C. (2002) · Cytokines Cellular & Molecular Therapy · doi:10.1080/13684730210002328 · Cited by 40
Cabillic, F., Bouet-Toussaint, F., Toutirais, O., Rioux-Leclercq, N. C., Fergelot, P., Pintière, C. T. D. L., Genetet, N., Patard, J. J., & Quémener, V. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03212.x · Cited by 38
Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis
Cénit, M. C., Simeón‐Aznar, C. P., VONK, M. C., Callejas-Rubio, J. L., Espinosa, G., Carreira, P. E., Blanco, F. J., Narváez, J., Tolosa, C., ROMÁN-IVORRA, J. A., et al. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.120506 · Cited by 38
Weissglas, M. G., Schamhart, D. H. J., Löwik, C. W. G. M., Papapoulos, S. E., Vos, P., & Kurth, K. (1995) · PubMed · Cited by 37
Melkamu, T., Kita, H., & O’Grady, S. M. (2012) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-012-0185-z · Cited by 37
Novel therapy for Crohn’s disease targeting IL-6 signalling
Ito, H. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.4.287 · Cited by 36
High serum levels of HIF-1α in psoriatic patients correlate with an over-expression of IL-6.
Vasilopoulos, Y., Sourli, F., Zafiriou, E., Klimi, E., Ioannou, M., Mamuris, Z., Simos, G., Koukoulis, G., & Roussaki-Schulze, A. (2013) · Cytokine · doi:10.1016/j.cyto.2013.02.029 · Cited by 36
Zhang, Y., Wang, X., Zhong, M., Zhang, M., Suo, Q., & Lv, K. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9840-7 · Cited by 35
Garg, R., Wollan, M., Galic, V., Garcia, R. L., Goff, B. A., Gray, H. J., & Swisher, E. M. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.043 · Cited by 35
Zhang, J., Xie, S., Ma, W., Yu, T., Tian, Y., Huang, X., & Zhang, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351197 · Cited by 30
Asschert, J. G. W., de Vries, E. G. E., de Jong, S., Withoff, S., & Vellenga, E. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<236::aid-ijc12>3.0.co;2-r · Cited by 30
Alberti, L., Bachelot, T., Duc, A., Biota, C., & Blay, J. (2005) · Cancer Research · doi:10.1158/0008-5472.2.65.1 · Cited by 30
Weissglas, M. G., Schamhart, D. H. J., Löwik, C. W. G. M., Papapoulos, S. E., Vos, P., & Kurth, K. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67735-8 · Cited by 30
Lee, Y. H., Lee, Y. H., Choi, S., Ji, J., & Song, G. G. (2011) · Lupus · doi:10.1177/0961203311422711 · Cited by 26
Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis
Yokota, S., & Kishimoto, T. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.41 · Cited by 24
Lamas, J. R., Rodríguez‐Rodríguez, L., Tornero-Esteban, P., Villafuertes, E., Hoyas, J. A., Abásolo, L., Varadé, J., Álvarez‐Lafuente, R., Urcelay, E., & Fernández‐Gutiérrez, B. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.025 · Cited by 24
Chari, A., Pri‐Chen, H., & Jagannath, S. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2012.12.010 · Cited by 22
Cardillo, M. R., & Ippoliti, F. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000105 · Cited by 20
Contact stimulation of fibroblasts for tenascin production by melanoma cells
Ádám, B., Tóth, L., Pásti, G., Balázs, M., & Ádány, R. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000205022.25397.86 · Cited by 17
Adachi, Y., Yoshio‐Hoshino, N., Aoki, C., & Nishimoto, N. (2010) · PubMed · Cited by 13
Ruff, K., Puetter, A., & Levy, L. S. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-35 · Cited by 12
Chang, S., Shin, C. S., Rho, S.-K., Kim, D.-K., & Kim, J. H. (1998) · PubMed · Cited by 7
Cited by
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Taniguchi, K., & Karin, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.001 · Cited by 716
Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells
Jang, S., Kwon, E.-J., & Lee, J. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020905 · Cited by 612
Interleukin-6: A Masterplayer in the Cytokine Network
Uciechowski, P., & Dempke, W. C. M. (2020) · Oncology · doi:10.1159/000505099 · Cited by 465
Role of Interleukin-6 in Depressive Disorder
Ting, E. Y.-C., Yang, A. C., & Tsai, S.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062194 · Cited by 385
Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption
Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Shen, W.-R., Qi, J., Nara, Y., Pramusita, A., Kinjo, R., & Mizoguchi, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145169 · Cited by 380
Metadata
- Authors
- Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 141
- Issue
- 2
- Pages
- 125-139
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1970433764
- Cited by
- 664
- References
- 239
- FWCI
- 18.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.